Physician profile
Lauren E Perlin
NPI 1295140770
$1,781.72
in general payments reported to CMS, 2019-2025
30 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $15.14 · 2021: $242 · 2022: $301 · 2023: $240 · 2024: $174 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $240.56 | 2021-2025 | Coolseal Generator, Novasure, Acessa Provu System |
| Medtronic, INC. | $215.28 | 2021-2025 | V-Loc 180, Truclear |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Abbvie INC. | $173.55 | 2019-2022 | |
| Nevro Corp. | $108.50 | 2019 | |
| Channel Medsystems, INC. | $101.36 | 2025 | |
| Daiichi Sankyo INC. | $95.87 | 2021-2025 | Injectafer |
| Organon LLC | $93.48 | 2023-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $68.04 | 2023-2025 | |
| Sage Therapeutics, LLC | $49.99 | 2024-2025 | Zurzuvae |
| Baxter Healthcare | $45.19 | 2025 | Perclot, Tisseel |
| Myovant Sciences INC. | $44.23 | 2022 | |
| Molnlycke Health Care US, LLC | $37.48 | 2022-2023 | Avance, Mepilex Border Post-Op |
| Exeltis, USA INC. | $31.54 | 2025 | Slynd |
| Pfizer INC. | $29.78 | 2019-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $27.44 | 2019-2022 | |
| Ethicon US, LLC | $23.38 | 2025 | Enseal, Vistaseal, Surgicel Nu-Knit |
| Meditrina | $23.01 | 2023 | |
| Merck Sharp & Dohme LLC | $22.21 | 2023 | Gardasil 9 |
| Shield Therapeutics INC | $18.96 | 2024 | |
| Therapeuticsmd, INC. | $16.93 | 2022 | |
| Dysis Medical, INC. | $16.72 | 2021 | |
| Evofem Biosciences, INC. | $16.64 | 2021 | |
| Mylan Pharmaceuticals INC. | $16.61 | 2022 | |
| Agile Therapeutics, INC. | $15.83 | 2021 | |
| Coopersurgical, INC. | $15.21 | 2021 | |
| Gynesonics, INC. | $14.74 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lupin INC. | $13.79 | 2019 | |
| Myriad Women'S Health, INC. | $13.27 | 2023 | Myrisk |
| Minerva Surgical, INC | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Perlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.